Home › Kanser sa Bato › Massachusetts › Boston

Pag-aaral pangklinika para sa Kanser sa Bato sa Boston, MA

Isang pag-aaral para sa Kanser sa Bato ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Nagre-recruitPhase 1

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05536141

Distance-Based Exercise to Preserve Function and Prevent Disability

Nagre-recruit

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 3

Research Site, Boston
Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07011719

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Nagre-recruitPhase 1/2

Brigham and Women's Hospital, Boston
Dana Farber/Mass General Brigham Cancer Care, Inc, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Nagre-recruitPhase 2

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07123090

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07195682

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT06026410

Video Education With Result Dependent dIsclosure

Nagre-recruit

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05225428

Drug Screening Using Novel IMD in Renal Cell Carcinoma

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT05700461

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT06239194

Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC

Nagre-recruitPhase 2

Beth Israel Deaconess Medical Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT07397611

Stereotactic Magnetic Resonance Guided Radiation Therapy

Nagre-recruit

Brigham & Women's Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2025 · NCT04115254

Pag-aaral para sa Kanser sa Bato sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.